Trials / Completed
CompletedNCT05495607
Continous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small Infants
Dialysis With CARPEDIEM®: French Multicentric Experience in 25 Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Academic / Other
- Sex
- All
- Age
- 0 Years – 3 Years
- Healthy volunteers
- Not accepted
Summary
Historically, CKRT and hemodialysis were performed in small infants and newborns with devices developed for adults with high rates of complications and mortality. We aim to retrospectively report the first multicenter French experience of CARPEDIEM® use and evaluate the efficacy, feasibility, outcomes, and technical considerations of this new device in a population of neonates and small infant. Compared to adult's device continuous renal replacement therapy with an adapted machine allowed successful blood purification without severe complications even in low birth weight neonates.
Conditions
- Hypoxic-Ischemic Encephalopathy
- Sepsis
- Kidney Diseases
- Metabolic Disease
- Twin to Twin Transfusion Syndrome
- Cardiac Disease
- Pulmonary Disease
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CARPEDIEN | Continuous renal replacement therapy |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2022-01-01
- Completion
- 2022-01-01
- First posted
- 2022-08-10
- Last updated
- 2022-08-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05495607. Inclusion in this directory is not an endorsement.